Multidisciplinary management of SCLC

Current practice. Emerging evidence.

Small cell lung cancer continues to evolve rapidly, with new developments in systemic therapy, cranial radiotherapy, biomarkers and biological subtyping influencing how the disease is approached in clinical practice.

This concise Summary Report brings together the key insights from the MediMix expert discussion on the multidisciplinary management of SCLC.

Prefer the full expert discussion?

Watch the complete webinar, including the expert discussion and Q&A


Accredited course